NCT02440581View on ClinicalTrials.gov

Renal Osteodystrophy: An Individual Management Approach

NACompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Kidney Failure, Chronic
Interventions
DRUG

Alendronate

DRUG

Teriparatide

DRUG

Cinacalcet

Trial Locations (1)

40536

University of Kentucky, Lexington

All Listed Sponsors
collaborator

Wright State University

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Hartmut Malluche, MD

OTHER

NCT02440581 - Renal Osteodystrophy: An Individual Management Approach | Biotech Hunter | Biotech Hunter